A groundbreaking blood test for colorectal cancer screening could reshape early detection. Learn how this FDA-approved method ...

Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and ...

Discover how the FIT test is transforming colorectal cancer screening, reducing mortality rates and offering a more ...

Faecal immunochemical test (FIT) has been reported to outperform guaiac faecal occult blood tests (gFOBT). The effectiveness of FIT in reducing colorectal cancer (CRC) mortality has been demonstrated ...

Breakthroughs in laboratory and data science are increasing interest in blood tests to screen for cancer, with colorectal ...

Background: Current guidelines for screening of colorectal cancer do not offer specific recommendations for cessation of antithrombotic agents prior to fecal occult blood test (FOBT). Aim ...

screening organizations and laboratories with a medium volume of fecal occult blood (FOB) and calprotectin tests. Using an immunochemical testing (FIT) method, the analyzer has a throughput of up ...

Under the agreement, Sysmex will distribute and service in Canada Sentinel Diagnostics' SentiFit 270 and SentiFit 800 analyzers for fecal immunochemical testing.